The rising costs of clinical trials may be partly due to steering committees composed of individuals far removed from the actual execution of research. A growing body of opinion suggests that when decision-makers lack frontline experience, they tend to prioritize bureaucratic box-checking over efficient, practical study design.
This disconnect creates layers of oversight that add expense without improving outcomes. Critics argue that the industrialization of trials has led to excessive administration that serves little purpose. True innovation in research, they say, demands a deep understanding of the realities on the ground, not just high-level oversight.
#ClinicalTrials #MedicalResearch #HealthcareInnovation #PharmaIndustry #TrialDesign